Immunovant
IMVT
#2550
Rank
C$9.85 B
Marketcap
C$47.60
Share price
-0.12%
Change (1 day)
43.69%
Change (1 year)

Earnings for Immunovant (IMVT)

Earnings in 2026 (TTM): -C$0.79 Billion

According to Immunovant's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$0.7 Billion a decrease over its 2024 earnings that were of -C$0.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Immunovant from 2019 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.79 Billion12.94%
2025 -C$0.7 Billion20.23%
2024 -C$0.59 Billion59.79%
2023 -C$0.37 Billion32.6%
2022 -C$0.28 Billion39.55%
2021 -C$0.2 Billion37.3%
2020 -C$0.15 Billion780.74%
2019 -C$16.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.23 Billion-72.41%๐Ÿ‡บ๐Ÿ‡ธ USA